What is the appropriate management of hypotension secondary to propranolol ingestion?

Management of Hypotension Secondary to Propranolol Ingestion

For hypotension from propranolol overdose, immediately initiate vasopressor therapy and high-dose insulin with dextrose supplementation, as these are the cornerstone treatments with the strongest evidence for improving outcomes in beta-blocker poisoning. 1

Initial Stabilization and Assessment

Propranolol is a highly lipophilic, non-selective beta-blocker that causes hypotension through multiple mechanisms: bradycardia, reduced cardiac contractility, and potential vasodilation from alpha-1 receptor antagonism 1. The hypotension is often refractory to standard therapy. Severe toxicity typically manifests within 2 hours of ingestion for immediate-release formulations 2.

Key clinical features to monitor:

• Cardiovascular: Bradycardia, hypotension, cardiogenic shock
• Neurological: Delirium, coma, seizures (due to high lipophilicity and CNS penetration) 2
• Metabolic: Hypoglycemia, hyperkalemia
• ECG: Sodium channel blockade (QRS widening) in severe cases 3

Pharmacological Management Algorithm

First-Line Therapy (Class I Recommendations)

1. Vasopressors (Class I, LOE C-LD)

• Initiate immediately for hypotension 1
• Readily available and act quickly
• Should be started while preparing other therapies

2. High-Dose Insulin Euglycemic Therapy (Class I, LOE B-NR)

• Recommended for hypotension refractory to or in conjunction with vasopressors 1
• Improves inotropy in cardiogenic shock from beta-blocker poisoning
• Superior outcomes with lower rates of vasoconstrictive complications compared to vasopressor-only therapy
• Must provide supplemental dextrose to maintain euglycemia 1

Second-Line Therapy (Class IIa Recommendations)

3. Glucagon (Class IIa, LOE C-LD)

• Bolus followed by continuous infusion for bradycardia or hypotension 1
• The FDA label specifically recommends 50-150 mcg/kg IV bolus followed by 1-5 mg/hour continuous infusion 4
• Increases contractility and improves hemodynamics through non-adrenergic mechanisms
• Particularly useful as it bypasses blocked beta-receptors

Additional Considerations (Class IIb)

4. Atropine (Class IIb, LOE C-LD)

• May be reasonable for beta-blocker-induced bradycardia 1
• Often ineffective as bradycardia is not vagally mediated

5. Electrical Pacing (Class IIb, LOE C-LD)

• May be reasonable for refractory bradycardia 1

Critical Pitfalls and Contraindications

AVOID Epinephrine

The FDA label explicitly warns that epinephrine may provoke uncontrolled hypertension in propranolol overdose due to unopposed alpha-receptor stimulation 4. Epinephrine is NOT indicated for propranolol overdose treatment.

Intravenous Lipid Emulsion (ILE) - NOT Recommended

Despite propranolol's high lipophilicity, ILE therapy is NOT likely to be beneficial for life-threatening beta-blocker poisoning (Class III: No Benefit, LOE C-LD) 1. While one animal study showed some benefit 5, the 2023 AHA guidelines explicitly recommend against its use based on lack of clinical efficacy.

Refractory Cases

VA-ECMO (Class IIa, LOE C-LD)

• Reasonable for life-threatening propranolol poisoning with cardiogenic shock refractory to maximal pharmacological interventions 1
• May be life-saving based on case series and observational studies
• Consider early in patients with persistent pump failure despite high-dose insulin and vasopressors

Dose-Toxicity Relationship

Recent prospective data shows:

• Severe toxicity threshold: ≥2,000 mg in isolated propranolol ingestion 3
• 53% of patients ingesting ≥2,000 mg developed severe toxicity (seizure, coma, inotrope requirement, sodium channel blockade, or cardiac arrest)
• All cardiac arrests occurred with doses ≥2,400 mg 3
• Co-ingestions (particularly benzodiazepines) occurred in 74% of cases and may modify presentation 3

Gastrointestinal Decontamination

If ingestion is recent, evacuate gastric contents with care to prevent pulmonary aspiration 4. Consider endoscopy if drug bezoar is suspected, particularly with large ingestions, as this can be a source of ongoing absorption 6.

Supportive Care Specifics

• Treat hypoglycemia with supplemental dextrose as standard care 1
• Monitor continuously: ECG, blood pressure, pulse, neurobehavioral status, intake/output 4
• Bronchospasm: Use isoproterenol or aminophylline if needed 4
• Median length of stay: 17 hours, but severe cases require ICU monitoring for 24+ hours 3

Summary Treatment Sequence

1. Immediate: Vasopressors + high-dose insulin with dextrose
2. Concurrent: Glucagon bolus and infusion
3. If refractory: Consider VA-ECMO
4. Avoid: Epinephrine, intravenous lipid emulsion
5. Monitor: For 24 hours minimum in severe cases

The outcome is usually favorable with aggressive supportive care, even in severe toxicity, provided treatment is initiated promptly 3.